- Women with a pathogenic mutation of the BRCA2 gene or othergenes who are at intermediate or high risk for breast cancer, as well as thosewho have not been tested but have first-degree relatives who are carriers ofsuch mutations should undergo annual mammography from the diagnosis of themutation but not before the age of 30 (categoryA). The gene discussed is BRCA2; the disease is breast carcinoma.